Language selection

Government of Canada / Gouvernement du Canada

Search

Updated guidance on respiratory syncytial virus (RSV) vaccines for older adults including the expanded use of RSVPreF3 for individuals 50-59 years of age and use of the new mRNA-1345 vaccine.: HP40-384/2025E-PDF ; HP40-384/2025-1E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.947789&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
  • Canada. National Advisory Committee on Immunization, issuing body.
TitleUpdated guidance on respiratory syncytial virus (RSV) vaccines for older adults including the expanded use of RSVPreF3 for individuals 50-59 years of age and use of the new mRNA-1345 vaccine.
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Directives mises à jour sur les vaccins contre le virus respiratoire syncytial (VRS) chez les personnes âgées, y compris l'utilisation élargie du VRSPreF3 chez les individus de 50 à 59 ans et l'utilisation du nouveau vaccin ARNm-1345.
  • On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
  • "Pub.: 240852"--Page 2.
  • "Pub.: 240854"--Page 2 (summary).
  • Includes bibliographical references (pages 47-51).
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, March 13, 2025.
  • ©2025
Description1 online resource (51 pages) + summary (5 pages)
ISBN9780660756226 9780660756233
Catalogue number
  • HP40-384/2025E-PDF
  • HP40-384/2025-1E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: